Document is current
Any future updates will be listed below
-
Authors
Gomez-Alonso, Monica del C.
Kretschmer, Anja
Wilson, Rory
Pfeiffer, Liliane
Karhunen, Ville
Seppälä, Ilkka
Zhang, Weihua
Mittelstraß, Kirstin
Wahl, Simone
Matias-Garcia, Pamela R.
Prokisch, Holger
Horn, Sacha
Meitinger, Thomas
Serrano-Garcia, Luis R.
Sebert, Sylvain
Raitakari, Olli
Loh, Marie
Rathmann, Wolfgang
Müller-Nurasyid, Martina
Herder, Christian
Roden, Michael
Hurme, Mikko
Jarvelin, Marjo-Riitta
Ala-Korpela, Mika
Kooner, Jaspal S.
Peters, Annette
Lehtimäki, Terho
Chambers, John C.
Gieger, Christian
Kettunen, Johannes
Waldenberger, Melanie https://orcid.org/0000-0003-0583-5093
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung
Munich Center of Health Sciences
Deutsche Forschungsgemeinschaft (WA 4081/1-1)
Bundesministerium für Bildung und Forschung (01EA1902A: Dimension)
Deutsches Zentrum für Diabetes Forschung
National Institute for Health Research (RP-PG-0407-10371)
British Heart Foundation (SP/04/002)
Medical Research Council (G0601966, G0700931)
Welcome Trust (084723/Z/08/Z, 090532, 098381)
NIHR Official Development Assistance (16/136/68)
European Union FP7 (EpiMigrant, 279143)
H2020 programs (iHealth-T2D, 643774)
Academy of Finland (322098, 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), 41071 (Skidi))
Social Insurance Institution of Finland
Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (X51001)
Diabetes Research Foundation of Finnish Diabetes Association
EU Horizon 2020 (755320 for TAXINOMISIS, grant 848146 for To_Aition)
European Research Council (742927)
European Union’s Horizon 2020 research and innovation programme
Academy of Finland (EGEA 285547)
Joint Programming Initiative A healthy diet for a healthy life (PREcise – MRC-UK P75416)
Consejo Nacional de Ciencia y Tecnología-México (710007)
Sigrid Juséliuksen Säätiö
Singapore Ministry of Health’s National Medical Research Council (NMRC/STaR/0028/2017)
- License Information
-
More Information
Article History
Received: 25 August 2020
Accepted: 22 October 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: The KORA cohort is approved by the local ethics committee Bayerische Landesärztekammer in Bayern, Germany. The LOLIPOP study is approved by the National Research Ethics Service (07/H0712/150). The NFBC1966 cohort is approved by the Ethics Committee of the Northern Ostrobothnia Hospital District. The YFS study is approved by the Ethics Committee of the Hospital District of Southwest Finland. All participants provided written informed consent to participate in the respective study.
: Not applicable.
: CH received honoraria from Lilly and Sanofi and a research Grant from Sanofi outside the submitted work.
